Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Aug 5.
Published in final edited form as: Adv Healthc Mater. 2015 Jun 3;4(11):1628–1633. doi: 10.1002/adhm.201500021

Microfluidic generation of monodisperse, structurally homogeneous alginate microgels for cell encapsulation and 3D cell culture

Stefanie Utech 1, Radivoje Prodanovic 1,2, Angelo S Mao 1, Raluca Ostafe 1,3, David J Mooney 1,4, David A Weitz 1,5
PMCID: PMC4529809  NIHMSID: NIHMS699213  PMID: 26039892

Abstract

Recent studies have shown that basic cellular behavior varies significantly between two- and three-dimensional culture systems. To identify the origins of these fundamental differences the design of reliable and precisely controlled environments is essential. While 2D cell culture is a well-established technique, the fabrication of defined three-dimensional culture models is still challenging. We present a new method for the microfluidic generation of a micron-sized three-dimensional cell culture system. We use a triggered ionic crosslink formation to generate highly monodisperse and structurally homogeneous alginate microbeads. Aqueous droplets containing a mixture of alginate and a water-soluble calcium-EDTA complex are formed by droplet-based microfluidics. In their complexed form, the calcium ions are homogenously distributed inside the droplet but not accessible for the crosslinking process. Acid addition is used to trigger the degradation of the complex, releasing calcium ions on demand that can physically crosslink the alginate chains. A homogeneous hydrogel network is thus generated which can be transferred into an aqueous environment without losing its structural integrity. Single cells can be encapsulated into these controlled microenvironments which provide structural support while allowing for continuous nutrient supply. We encapsulate individual mesenchymal stem cells (MSCs) into the microbeads which show the aspired cell growth and proliferation.

graphic file with name nihms699213f5.jpg

Keywords: microfluidics, microgel, alginate, cells, encapsulation


Micron-sized alginate particles are used for the encapsulation of living cells in pharmaceutical research, tissue engineering and regenerative medicine.15 Such microgels act as micron-sized 3D culturing units allowing individual cells to be independently monitored or manipulated for example to study the role confinement on cell fate or to deliver cells for the repair of damaged tissue.6,7 The ideal microgel particles for these applications should be composed of a homogenous network structure to allow the stable entrapment of the encapsulated cell in a controlled microenvironment with precise internal structure. Additionally, particle sizes should be small (< 200 µm) to allow effective delivery of oxygen and nutrients to the encapsulated cell which is essential for cell viability and health.810 In tissue engineering, cell-containing microgels are also used as building blocks which are assembled into larger architectures mimicking the structure of tissues and organs.7,11 Since cell-cell distances and structural arrangement have significant influence on cellular properties and function, a precise control over size and size distribution is of key importance.12

Alginate microgel particles can be produced by means of droplet-based microfluidics which combines high-throughput production with precise control over size, shape and morphology of the generated droplets.3,9,1315 Typically, an aqueous alginate solution is emulsified in an oil phase and crosslinked ionically with bivalent ions such as Ca2+. The ionic crosslinking process occurs immediately upon contact of alginate chains and calcium ions. The fast reaction typically results in uncontrolled gelation within the microfluidic device which can cause clogging and non-uniform drop formation.8,16 To overcome these problems, the drop formation and the gelation reaction must be separated. Thus, calcium ions need to be delivered to the alginate solution without inducing unintended gelation prior to drop formation.

One route to achieve this goal is the use of calcium carbonate (CaCO3) nanoparticles.2,13,17 The water-insoluble particles are dispersed in the alginate solution and can be dissolved under acidic conditions after drop formation. Premature gelation is avoided and monodisperse particles result. However, the dissolution of solid calcium salt particles causes a heterogeneous distribution of calcium ions inside the droplets and diminishes the homogeneity of the resulting particles. Additionally, clogging of small microfluidic channels in the presence of particle aggregates limits the range of accessible microgel dimensions.13 Other techniques involves the initiation of the crosslinking process by the delivery of calcium chlorides or acetate particles through the oil phase which are subsequently dissolved in the emulsion droplet.17,28 Nevertheless, this method can suffer from the same problems, namely inhomogeneous calcium distribution or clogging issues. Alternatively, the generation of alginate microgels via coalescence of separate droplets containing alginate and calcium chloride has been tried.18 However, mixing inside the coalesced droplets still results in heterogeneous particles since crosslinking takes place before a homogenous distribution of calcium ions can be achieved. Additionally, coalescence generally results in a volume increase of the final, crosslinked alginate microgels.17

If we were able to control the crosslinking process, homogenous microgel particles with reliable and precisely tunable particle properties would become accessible. This would allow us to study the influence of the physical properties of the microgel matrix on the behavior of the encapsulated cell in three dimensions which is of great importance for applications in tissue engineering, stem cell research and the treatment of diseases.1921 However, the limited homogeneity of available alginate microgels particles restricts these applications.

In this communication, we present a method for the fabrication of monodisperse alginate microgels with structural homogeneity via droplet-based microfluidics. We deliver calcium ions in form of a water-soluble calcium-ethylenediaminetetraacetic acid (calcium-EDTA) complex. By chelating the calcium ions with EDTA, the ions remain in solution but are inaccessible to the alginate chains. Using droplet-based microfluidics, we emulsify a perfectly homogenous mixture of alginate and the chelated calcium ions without inducing unintended gelation. By addition of acetic acid to the continuous phase, we trigger the dissociation of the complex and release calcium ions after drop formation. The free ions react with the alginate chains in a highly controlled fashion forming alginate microgels with excellent structural homogeneity. By separating drop formation and crosslinking in this purely aqueous system, we eliminate clogging issues and generate alginate microgel particles with particle size down to ten micrometers and narrow particle size distributions. We demonstrate that the gelation process is suitable for the encapsulation of living cells by encapsulating individual mesenchymal stem cells (MSCs). Our mild polymerization technique allows us to encapsulate the cells with high viability. We culture and monitor the encapsulated cells inside the microgels over the course of two weeks within which we observe stable encapsulation, healthy cells, growth and proliferation.

We prepare monodisperse, structurally homogeneous alginate microgels in the size range of 10 – 50 µm by acidic dissociation of a water-soluble calcium-EDTA complex within an alginate containing emulsion droplet. We form the calcium-EDTA complex by mixing a solution of calcium chloride (100 mM) with a solution of disodium-EDTA (100 mM) in equal ratios, schematically illustrated in Figure 1 We adjust the pH value of the solution using sodium hydroxide until we reach a pH of 7. Under neutral conditions the complex is highly stable. The chelation of calcium ions with EDTA keeps the ions in solution but impedes their reaction with alginate chains. We thus prepare a homogenous mixture of the aqueous calcium-EDTA complex solution (50 mM) and an aqueous alginate solution (2 wt% MVG, Novamatrix). We use a FITC-labeled alginate, prepared using carbodiimide chemistry, which enables visualization of the internal structure of the microgel after polymerization using fluorescence microscopy.7 The premixed alginate-calcium-EDTA complex solution is emulsified into monodisperse droplets using a microfluidic flow-focusing device as shown in Figure 1b,c. Fluorinated carbon oil (HFE7500, 3M) containing 1 wt% of a biocompatible surfactant is used as the continuous phase.22 After drop formation, gelation is induced by addition of acetic acid (0.05 vol%) to the oil phase. The acid diffuses into the droplets and causes a decrease in pH, leading to the dissociation of the Ca-EDTA complex and the release of calcium ions. The liberated calcium ions then react with the alginate chains creating uniformly crosslinked microgel particles, illustrated in Figure 1d. After gelation, the microgels are transferred into aqueous medium. The water-soluble nature of the complex eliminates clogging issues arising in case of solid crosslinking precursors and allows the homogenous distribution of calcium ions inside the aqueous droplet prior to gelation.2,13,17 We avoid premature gelation by the time-controlled dissociation of the complex which furthermore allows the separation of drop formation and crosslinking process resulting in a highly controlled and consequently, reliable and reproducible drop and subsequent particle generation. Bright-field images of the microgels, taken after transfer to an aqueous medium reveal the high monodispersity of the particles as shown in Figure 2a. Fluorescence microscopy images illustrate the internal morphology of the microgel particles. The fluorescence intensity and consequently the concentration of alginate are homogenous throughout the particle confirming the expected structural homogeneity, visible in Figure 2b. A comparison between different preparation methods of microfluidically generated alginate microgels nicely demonstrates the superior homogeneity of the presented particles as shown in Figure S1.

Figure 1.

Figure 1

Microfluidic generation of homogeneously crosslinked alginate microparticles by on demand release of calcium ions from a water-soluble calcium-EDTA complex. a) Reaction scheme for the formation and dissociation of the calcium-EDTA complex. Under neutral conditions (pH 7.0) the calcium ions are chelated by the EDTA molecules. In an acidic environment (pH 5.0), the reverse reaction takes place resulting in a release of calcium ions which can then form an ionic network with the alginate chains. b,c) Schematic illustration (b) and microscopic image (c) of the microfluidic flow-focusing device used for the fabrication of alginate microbeads (scale bar: 50 µm). d) Schematic illustration of the crosslinking process. Upon addition of acid to the continuous phase, the calcium-EDTA complex dissolves, calcium ions are released and crosslinking of alginate is induced.

Figure 2.

Figure 2

a,b) Bright-field and fluorescent images of alginate microbeads after transfer into aqueous medium. The images reflect the high monodispersity of the spherical particles. The high-magnification fluorescent image reveals the homogeneous structure of the alginate microbeads. c-f) Representative bright-field images and corresponding size distribution histograms of homogeneous alginate microbeads with 10, 25, 40 and 50 µm in diameter. The gels are prepared using three different microfluidic devices (10 µm, 25 µm and 50 µm channels). The flow rate of the inner phase (alginate-calcium-EDTA) solution is 50 µL/h. The flow rate of the continuous oil phase is varied between 100 µL/h and 500 µL/h to adjust the size of the droplets for a given microfluidic device. By separating the gelation from the drop formation process and the use of merely water-soluble materials a precise control of the drop formation and hence, particle size and size distribution is achieved. All scale bars are 50 µm.

Alginate microgels can also be prepared by using higher concentration of the calcium-EDTA complex (data not shown). However, the limited solubility of EDTA in water which is around 0.26 M at 20°C can cause the formation of insoluble precipitates which impedes the aspired structural homogeneity. The same problem occurs for calcium-EDTA concentrations higher than 100 mM when mixed with 2 % alginate. The concentration of calcium-EDTA can also be lower than the ones applied here. However, the critical calcium concentration necessary to ensure complete gelation of alginate has been reported to be in the order of 25 mM.27 The relation between calcium-EDTA concentration and drop formation efficiency is illustrated in Figure S2. A 2% alginate concentration is the highest concentration that can be used under the presented conditions. The high viscosity of alginate solutions with concentrations higher than 2 wt% result in debonding of the microfluidic device due to the high pressures generated inside the microchannels, especially in case of small dropmakers.

The size of the alginate microgels can be adjusted by changing the size of the microfluidic device and the applied flow rates. We use three flow-focusing devices with different square cross-sectional dimensions. We keep the flow rate of the alginate-calcium-EDTA solution constant (50 µL/h) while varying the flow rate of the continuous phase from 100 µL/h to 500 µL/h, thereby decreasing the drop size for a given dropmaker. We prepare particles as small as 10 µm using a microfluidic device with a 10-µm-square cross-sectional channel. Larger gel sizes are made with larger microfluidic channels as shown for 25 µm, 40 µm and 50 µm particles. All samples exhibit narrow size distributions and excellent homogeneity, illustrated in Figure 2c-f.

We demonstrate the suitability of the method presented for 3D cell culture application by encapsulating living mesenchymal stem cells (MSCs) into microgels. We choose a cell type which demonstrates an increased susceptibility to stress and the properties of the surrounding microenvironment.23 We prepare a peptide-functionalized (Arg-Gly-Asp, RGD) alginate (MVG, Novamatrix) using carbodiimide chemistry.7 The RGD sequence offers integrin binding sites which allow the attachment of the encapsulated cells to the alginate network, a necessary requirement for cellular growth of adherent cells like MSCs.7,23 After dissolution of the RGD-labeled alginate (2 wt%) in cell culture medium (DMEM supplemented with 10% FBS and 1% penicillin/streptomycin (Invitrogen), the calcium-EDTA complex (50 mM) is added and the solution is vortexed to ensure homogenous mixing. Prior to emulsification, the cells are routinely cultured, trypsinized and resuspended in the alginate-calcium-EDTA solution. We use a cell density of 3.6 × 106 cells/mL. The cell-containing alginate-Ca-EDTA mixture is emulsified into monodisperse droplets using a flow-focusing device as shown in Figure 3a. We find that this cell density results in 25 % of the droplets generated carrying single cells while the majority of drops (70 %) remains empty. The number of drops in which more than one cell is encapsulated is small, and is in good agreement with the number expected from the Poisson distribution as illustrated in Figure 3b.24,25 This number can be set by adjusting the cell density accordingly.24 Gelation of the droplets is induced by subsequent addition of acetic acid (0.05 vol%) to the oil phase. Under these conditions, we find that a crosslinking time of two minutes is sufficient to ensure complete gelation of the droplets. After crosslinking, the gels are washed to remove residual acid and EDTA and redispersed in cell culture medium. Using a calcein-AM assay, we stain the living cells inside the microgels and find that 83 % of the cells remain viable after encapsulation and crosslinking. Longer crosslinking times, i.e. extended exposure of the encapsulated cells to the acidic environment result in increased cell mortality. After 30 minutes of crosslinking no living cells remain as illustrated in Figure 3c. Higher concentrations of acetic acid during the crosslinking period show the same effect (data not shown). Lower concentrations of acetic acid are not sufficient to induce complete gelation of the particles as shown in Figure S3. We incubate and culture the encapsulated MSCs under a CO2 atmosphere at 37 °C to ensure optimal culturing conditions. The cells are clearly embedded in the microcompartments formed by the alginate hydrogels; the microgels remain intact and we observe no leakage of cells after encapsulation or while being cultured. We find that the cells keep their spherical shape when being cultured inside the microgel particle as shown in Figure 4a; this has also been reported for bulk three dimensional culture systems.23,26 Huebsch and colleagues were able to show that cells encapsulated in RGD-functionalized alginate interact with the surrounding matrix via αV integrins while maintaining their spherical shape.23 The cells are therefore able to adhere to the hydrogel matrix and maintain in a healthy and viable state inside the hydrogel matrix. After incubating the cells for several days, we see growth and proliferation of the cells inside the microgel particles. We observe cell division reflected by an increase in the number of cells present in the microgel matrix as is shown, for example, for cell-containing microgels that had been encapsulated for 15 days in Figure 4b. We find a high cell viability of 70% after two weeks of culture and observe only a slight decrease in the cell viability with proceeding incubation time as illustrated in Figure 4c. We believe that the cell viability can be further increased by adjustment of the hydrogel’s mechanical properties and degradation behavior. The degradation behavior of alginate can be enhanced by γ-irradiation or controlled oxidation which has been shown to significantly improve the viability of encapsulated cells.29,30 Alternatively, composites of alginate and a degradable polymer like gelatin can be used to enhance the cell viability during long-term culture.31,32 Nevertheless, the cellular growth and proliferation observed confirm efficient solid support as well as sufficient delivery of nutrients and oxygen to the encapsulated cells as shown in Figure 4d. This method can thus not only be used for the encapsulation of living cells but also for culturing of cells in highly controlled microgel matrices and may help to gain insights in cellular behavior in 3-dimensional environments. Additionally, the described incorporation of degradable moieties can be used to investigate cell-matrix interactions in further detail and study the self-organization of cells with proceeding degradation of the surrounding matrix.

Figure 3.

Figure 3

Microfluidic fabrication of cell-laden microbeads. a) Cells are encapsulated using a 50 µm flow-focusing device (scale bar: 100 µm). Single-cell containing droplets are indicated by white arrows. b) The encapsulation process follows the Poisson distribution and results in approximately 25 % of single-cell containing droplets with negligible multi-cell encapsulation. c) The cell viability is highly dependent on the gelation time of the microbeads. By limiting the gelation time to 2 minutes, a cell viability of 83 % after encapsulation is achieved (*=viability of cells before encapsulation).

Figure 4.

Figure 4

a) Microscopic image of alginate microgels directly after cell encapsulation and transfer into aqueous medium. In good agreement with the Poison statistics, the majority of gels is empty and several single-cell containing gels are visible. b) After 15 days in culture, gels containing multiple cells are present. We observe no leakage of cells or disintegration of the microgel matrix during this periode. c) Cell viability is determined via calcein staining. After 15 days in culture we determine a viability of 70 %. d) Representative images of cell-containing alginate gels directly after encapsulation and after being cultured for 3, 6, 12 and 15 days, reprehensively. The cells grow and proliferate inside the generated microenvironments while maintaining their spherical morphology. The encapsulated cells are stained using a calcein assay and analyzed via confocal laser scanning microscope to determine the cell viability (inlets). All scale bars are 25 µm.

In conclusion, we present a new method for the microfluidic fabrication of monodisperse alginate microgels with superior structural homogeneity. The use of a water-soluble calcium complex as crosslinking precursor allows us to homogenously distribute calcium ions within the generated alginate droplets. Subsequently, the dissociation of the complex is triggered by pH reduction resulting in the gelation of the droplets. We present the suitable of this approach for the encapsulation of living mesenchymal stem cells which are cultured inside the generated microenvironments for 15 days. During this period, we observe a stable encapsulation, cell growth and proliferation. We believe that this method will enable a precise tuning of the mechanical properties of the microgel through control of the amount of crosslinker and the nature of the alginate chains. This will help generate reliable three-dimensional cell culture systems for the investigation the relation between matrix characteristics and cell behavior in three dimensions; this is of major importance for stem cell research, wound healing and the treatment of diseases. The small size of the microgels is attractive for applications such as injectable cell-delivery systems in regenerative medicine allowing the delivery of cells to repair damaged tissue in a minimally invasive fashion. Finally, these tailored microenvironments serve as building blocks that can be assembled into more complex structural arrangements mimicking the complexity of real biological systems like tissues or organs. Thus, more realistic model systems are available which will result in more physiologically relevant data obtained from in vitro cultures, for example, in drug testing and development or tissue engineering applications.

Supplementary Material

Supporting Information

Acknowledgements

This work was supported by the National Institute of Health (R01 EB014703 and P01GM096971), the National Science Foundation (DMR-1310266) and the Harvard MRSEC (DMR-0820484). S.U. was supported by Deutsche Forschungsgemeinschaft (DFG). R. P. would like to thank the Fulbright Foundation for financial support (N0009552407).

References

  • 1.Lee KY, Mooney DJ. Progress in Polymer Science. 2012;37:106. doi: 10.1016/j.progpolymsci.2011.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tan WH, Takeuchi S. Advanced Materials. 2007;19:2696. [Google Scholar]
  • 3.Martinez CJ, Kim JW, Ye C, Ortiz I, Rowat AC, Marquez M, Weitz D. Macromolecular Bioscience. 2012;12:946. doi: 10.1002/mabi.201100351. [DOI] [PubMed] [Google Scholar]
  • 4.Sugiura S, Oda T, Izumida Y, Aoyagi Y, Satake M, Ochiai A, Ohkohchi N, Nakajima M. Biomaterials. 2005;26:3327. doi: 10.1016/j.biomaterials.2004.08.029. [DOI] [PubMed] [Google Scholar]
  • 5.Tumarkin E, Kumacheva E. Chemical Society Reviews. 2009;38:2161. doi: 10.1039/b809915b. [DOI] [PubMed] [Google Scholar]
  • 6.Wang H, Leeuwenburgh SC, Li Y, Jansen JA. Tissue Eng Part B Rev. 2012;18:24. doi: 10.1089/ten.teb.2011.0184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rowley JA, Madlambayan G, Mooney DJ. Biomaterials. 1999;20:45. doi: 10.1016/s0142-9612(98)00107-0. [DOI] [PubMed] [Google Scholar]
  • 8.Velasco D, Tumarkin E, Kumacheva E. Small. 2012;8:1633. doi: 10.1002/smll.201102464. [DOI] [PubMed] [Google Scholar]
  • 9.Wan J. Polymers. 2012;4:1084. [Google Scholar]
  • 10.Huang KS, Lai TH, Lin YC. Front Biosci. 2007;12:3061. doi: 10.2741/2295. [DOI] [PubMed] [Google Scholar]
  • 11.Khademhosseini A. The FASEB Journal. 2014:28. [Google Scholar]
  • 12.Bhatia SN, Balis UJ, Yarmush ML, Toner M. Faseb J. 1999;13:1883. doi: 10.1096/fasebj.13.14.1883. [DOI] [PubMed] [Google Scholar]
  • 13.Zhang H, Tumarkin E, Sullan RMA, Walker GC, Kumacheva E. Macromolecular Rapid Communications. 2007;28:527. [Google Scholar]
  • 14.Chung BG, Lee K-H, Khademhosseini A, Lee S-H. Lab on a Chip. 2012;12:45. doi: 10.1039/c1lc20859d. [DOI] [PubMed] [Google Scholar]
  • 15.Hu Y, Wang Q, Wang J, Zhu J, Wang H, Yang Y. Biomicrofluidics. 2012;6:026502. doi: 10.1063/1.4720396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Orive GH, María Rosa, Gascón Alicia R, Calafiore Riccardo, Chang Thomas MS, de Vos Paul, Hortelano Gonzalo, Hunkeler David, Lacík Igor, Shapiro AM James, Pedraz José Luis. Nature medicine. 2003;9:104. doi: 10.1038/nm0103-104. [DOI] [PubMed] [Google Scholar]
  • 17.Zhang H, Tumarkin E, Peerani R, Nie Z, Sullan RMA, Walker GC, Kumacheva E. Journal of the American Chemical Society. 2006;128:12205. doi: 10.1021/ja0635682. [DOI] [PubMed] [Google Scholar]
  • 18.Choi C-H, Jung J-H, Rhee Y, Kim D-P, Shim S-E, Lee C-S. Biomed Microdevices. 2007;9:855. doi: 10.1007/s10544-007-9098-7. [DOI] [PubMed] [Google Scholar]
  • 19.Hynes RO. Science. 2009;326:1216. doi: 10.1126/science.1176009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Discher DE, Mooney DJ, Zandstra PW. Science. 2009;324:1673. doi: 10.1126/science.1171643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Geiger B, Bershadsky A. Cell. 2002;110:139. doi: 10.1016/s0092-8674(02)00831-0. [DOI] [PubMed] [Google Scholar]
  • 22.Holtze C, Rowat AC, Agresti JJ, Hutchison JB, Angile FE, Schmitz CHJ, Koster S, Duan H, Humphry KJ, Scanga RA, Johnson JS, Pisignano D, Weitz DA. Lab on a Chip. 2008;8:1632. doi: 10.1039/b806706f. [DOI] [PubMed] [Google Scholar]
  • 23.Huebsch N, Arany PR, Mao AS, Shvartsman D, Ali OA, Bencherif SA, Rivera-Feliciano J, Mooney DJ. Nat Mater. 2010;9:518. doi: 10.1038/nmat2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Koster S, Angile FE, Duan H, Agresti JJ, Wintner A, Schmitz C, Rowat AC, Merten CA, Pisignano D, Griffiths AD, Weitz DA. Lab on a Chip. 2008;8:1110. doi: 10.1039/b802941e. [DOI] [PubMed] [Google Scholar]
  • 25.Clausell-Tormos J, Lieber D, Baret J-C, El-Harrak A, Miller OJ, Frenz L, Blouwolff J, Humphry KJ, Köster S, Duan H, Holtze C, Weitz DA, Griffiths AD, Merten CA. Chemistry & Biology. 2008;15:427. doi: 10.1016/j.chembiol.2008.04.004. [DOI] [PubMed] [Google Scholar]
  • 26.Benoit DS, Schwartz MP, Durney AR, Anseth KS. Nature materials. 2008;7:816. doi: 10.1038/nmat2269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Poncelet D. Annals of the New York Academie of Sciences. 2001;944:74. doi: 10.1111/j.1749-6632.2001.tb03824.x. [DOI] [PubMed] [Google Scholar]
  • 28.Lian M, Collier CP, Doktycz MJ, Retterer ST. Biomicrofluidics. 2012;6:044108. doi: 10.1063/1.4765337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kong HJ, Smith MK, Mooney DJ. Biomaterials. 2003;24:4023. doi: 10.1016/s0142-9612(03)00295-3. [DOI] [PubMed] [Google Scholar]
  • 30.Kong HJ, Kaigler D, Kim K, Mooney DJ. Biomacromolecules. 2004;5:1720. doi: 10.1021/bm049879r. [DOI] [PubMed] [Google Scholar]
  • 31.Sarker B, Papageorgiou DG, Silva R, Zehnder T, Noor FG-E, Bertmer M, Kaschta J, Chrissafis K, Detsch R, Boccaccini AR. J. Mater. Chem. B. 2014;2:1470. doi: 10.1039/c3tb21509a. [DOI] [PubMed] [Google Scholar]
  • 32.Sarker B, Singh R, Silva R, Roether JA, Kaschta J, Detsch R, Schubert DW, Cicha I, Boccaccini AR. PLoS One. 2014;9:e107952. doi: 10.1371/journal.pone.0107952. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES